Overview

Efficacy and Safety of Glucocorticosteroid Treatment in the Patients With Chronic Recurrent DILI

Status:
Completed
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
This study is to observe the efficacy and safety of glucocorticosteroid treatment in the patients with chronic recurrent drug-induced liver injury (DILI).
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Beijing 302 Hospital
Treatments:
Alprostadil
Glycyrrhizic Acid
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate
Ursodeoxycholic Acid